Bon Natural Life (BON) Prices 8.33M Share Offering at $2.16/sh

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has priced a best efforts offering of units as described below for aggregate gross proceeds to the Company of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company.

The offering of ordinary units (or pre-funded units in lieu of such ordinary units) comprised of 8,333,332 shares of the Company’s Class A ordinary shares (or pre-funded warrants in lieu of Class A ordinary shares for the pre-funded units), Series A Warrants to purchase one Class A ordinary shares at an exercise price of $1.44 per share (the “Series A Warrants”) and Series B Warrants to purchase Class A ordinary shares at an exercise price of $2.16 per share (the “Series B Warrants” and, together with the Series A Warrants, the “Warrants”). The pre-funded warrant will be exercisable immediately upon issuance and will expire when exercised in full. The Warrants will be immediately exercisable upon issuance and will expire on the three year anniversary of their initial exercise date.

The purchase price of each ordinary unit will be $1.44, and the purchase price of each pre-funded unit will be equal to such price minus $0.001.

The Company intends to use the net proceeds from this offering for sales network expansion, research and development, production capacity expansion, and working capital and other general corporate purposes. The offering is expected to close on or about March 18, 2025, subject to satisfaction of customary closing conditions.

Univest Securities, LLC is acting as sole placement agent for the offering.

The securities described above are being offered by the Company pursuant to a registration statement on Form F-1 (File No. 333-283333), as amended, previously filed and declared effective by the Securities and Exchange Commission (the “SEC”). This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. The offering is being made only by means of a preliminary prospectus and final prospectus that will form a part of the registration statement. A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus relating to this offering may be obtained, when available, by contacting Univest Securities, LLC at [email protected], or by calling +1 (212) 343-8888.

You May Also Be Interested In

• Amaero postpones U.S. IPO citing adverse market conditions
• Saratoga Investment prices $20.08M in 8.00% notes due 2031
• TransUnion CFO Todd Cello to step down after 29 years